BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 6788000)

  • 1. [African aspects of vaccination in prevention of purulent meningitis].
    Rey M
    Ann Soc Belg Med Trop; 1980 Sep; 60(3):237-52. PubMed ID: 6788000
    [No Abstract]   [Full Text] [Related]  

  • 2. [Suppurative bacterial meningitis and the outlook for specific prevention].
    Demina AA; Deviatkina NP
    Zh Mikrobiol Epidemiol Immunobiol; 1984 May; (5):3-10. PubMed ID: 6429984
    [No Abstract]   [Full Text] [Related]  

  • 3. Should we plan a general childhood vaccination against bacterial meningitis?
    Mäkelä PH; Peltola H
    Dev Biol Stand; 1979; 43():61-7. PubMed ID: 42596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Preventive effectiveness of an urgent mass vaccination with purified meningococcal polysaccharide vaccine observed during a meningitis epidemic].
    Wu C
    Zhonghua Liu Xing Bing Xue Za Zhi; 1985 Dec; 6(6):344-6. PubMed ID: 3938683
    [No Abstract]   [Full Text] [Related]  

  • 5. [Chemoprophylaxis in meningitis].
    Otero MC; Calvo MA; Pérez-Tamarit D; Asensi F
    Rev Esp Quimioter; 1998 Jun; 11(2):118-27. PubMed ID: 9795296
    [No Abstract]   [Full Text] [Related]  

  • 6. Selective primary health care: strategies for control of disease in the developing world. XIII. Acute bacterial meningitis.
    Greenwood BM
    Rev Infect Dis; 1984; 6(3):374-89. PubMed ID: 6429812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Survey on efficacy of inoculating purified polysaccharide vaccines as an emergency measure in preventing epidemic meningitis].
    Xu CH
    Zhonghua Liu Xing Bing Xue Za Zhi; 1982 Dec; 3(6):328-30. PubMed ID: 6821030
    [No Abstract]   [Full Text] [Related]  

  • 8. Control of epidemic meningococcal meningitis by mass vaccination. I. Further epidemiological evaluation of groups A and C vaccines in northern Nigeria.
    Mohammed I; Obineche EN; Onyemelukwe GC; Zaruba K
    J Infect; 1984 Sep; 9(2):190-6. PubMed ID: 6438244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of epidemic meningococcal meningitis by mass vaccination.
    Mohammed I; Zaruba K
    Lancet; 1981 Jul; 2(8237):80-2. PubMed ID: 6113451
    [No Abstract]   [Full Text] [Related]  

  • 10. Prophylaxis of bacterial meningitis.
    Peltola H
    Infect Dis Clin North Am; 1999 Sep; 13(3):685-710, viii. PubMed ID: 10470562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A serogroup A meningococcal polysaccharide vaccine: studies in the Sudan to combat cerebrospinal meningitis caused by Neisseria meningitidis group A.
    Erwa HH; Haseeb MA; Idris AA; Lapeyssonnie L; Sanborn WR; Sippel JE
    Bull World Health Organ; 1973; 49(3):301-5. PubMed ID: 4211056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of meningococcal infection in the African meningitis belt by selective vaccination.
    Greenwood BM; Wali SS
    Lancet; 1980 Apr; 1(8171):729-32. PubMed ID: 6103155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bacterial polysaccharide vaccines: Meningococcus, Pneumococcus, Haemophilus influenzae].
    Triau R
    Rev Prat; 1984 Jun; 34(31):1683-90. PubMed ID: 6429835
    [No Abstract]   [Full Text] [Related]  

  • 14. Meningococcal meningitis.
    Lancet; 1989 Mar; 1(8639):647-8. PubMed ID: 2564462
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of bacterial vaccines for prevention of pneumococcal and meningococcal disease in the day care setting.
    Broome CV
    Rev Infect Dis; 1986; 8(4):584-8. PubMed ID: 3092300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Editorial retrospective. Meningococcal A and other polysaccharide vaccines. A five-year progress report.
    Lepow ML; Gold R
    N Engl J Med; 1983 May; 308(19):1158-60. PubMed ID: 6403865
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevention of bacterial meningitis. Vaccines and chemoprophylaxis.
    Lieberman JM; Greenberg DP; Ward JI
    Infect Dis Clin North Am; 1990 Dec; 4(4):703-29. PubMed ID: 2126022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control of epidemic meningococcal meningitis by mass vaccination. II. Persistence of antibody four years after vaccination.
    Mohammed I; Onyemelukwe GC; Obineche EN; Gupta N; Oyeyinka GO
    J Infect; 1984 Sep; 9(2):197-202. PubMed ID: 6438245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccines against meningococcal meningitis: current status.
    Epidemiol Bull; 1994 Jul; 15(2):13-5. PubMed ID: 8086300
    [No Abstract]   [Full Text] [Related]  

  • 20. Right age for Meningococcal vaccine.
    John TJ
    Indian Pediatr; 1998 Jul; 35(7):669-70. PubMed ID: 10216680
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.